The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:
---------
Skillcast Group PLC - London-based e-learning software and content - Posts a 20% rise in revenue to £4.5 million for the six months ended on June 30 from £3.7 million a year ago, driven by a 33% increase in subscription revenue predominantly from new customers. Annualised recurring revenue rises by 26% to £6.3 million from £5.0 million a year ago. However, it swings to a pretax loss of £285,188 from a profit of £298,755, as administrative expenses jump to £3.4 million from £2.3 million a year ago. Declares an interim dividend of 0.168 pence per share, down 11% from 0.188p a year prior. Skillcast remains confident in achieving full-year expectations.
---------
Blancco Technology Group PLC - data security company - Records a 9.0% increase in revenue to £39.8 million in the six months ended on June 30, from £36.5 million a year ago. Pretax profit jumps by 14% to £1.7 million from £1.5 million. Cost of sales falls by 54% to £1.3 million from £2.8 million a year ago. Expects continued strong growth in future periods as the company enters the new financial year. Remains confident.
---------
Mobile Tornado Group PLC - Harrogate, England-based communications company - Posts revenue of £1.1 million for the six months ended on June 30, down 15% from £1.3 million a year ago. Pretax loss widens to £775,000 from £378,000, as operating expenses increase to £1.3 million from GBPo1.2 million, ‘adversely impacted by the depreciation of sterling comparative to the previous period’, the firm explains. Looking ahead, Mobile Tornado says confident that the business will emerge from ‘difficult’ two years. Focuses on moving the business back to profitability by the end of 2022.
---------
OptiBiotix Health PLC - York-based probiotics developer tackling cardiovascular diseases and lifestyle conditions - Reports a fall of 89% in revenue to £118,898 for the six months ended June 30, from £1.1 million a year ago. Says ‘lower than expected first half revenue caused by delays in restocking by certain large partners and in securing regulatory approval for some planned product launches’. Operating loss widens to £1.1 million from just £565,784. Pretax profit dips by 2.8% to £13.9 million from £14.3 million a year ago. Notes year-on-year comparisons are ‘challenging’ owing to the initial public offering of ProBiotix Health PLC in March. Looking ahead, OptiBiotix says its balance sheet is healthy, with sales prospects improving.
---------
Copyright 2022 Alliance News Limited. All Rights Reserved.
